Hot Features
Premium
Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 988,365 |
|
|||||
| News | - | ||||||
| Day High | 17.35 | Low High |
|||||
| Day Low | 17.01 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Acadia Pharmaceuticals Inc | ACAD | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.12 | -0.70% | 17.07 | 18:05:09 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 17.26 | 17.01 | 17.35 | 17.07 | 17.19 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,579 | 988,365 | US$ 17.15 | US$ 16,948,275 | - | 16.765 - 33.99 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:13:00 | 5 | US$ 17.07 | USD |
Acadia Pharmaceuticals (ACAD) Options Flow Summary
Acadia Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 2.81B | 164.77M | - | 726.44M | -61.29M | -0.37 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Acadia Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACAD Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 17.90 | 17.90 | 16.765 | 17.16 | 1,181,064 | -0.83 | -4.64% |
| 1 Month | 18.67 | 18.995 | 16.765 | 17.88 | 1,398,551 | -1.60 | -8.57% |
| 3 Months | 27.44 | 27.94 | 16.765 | 21.97 | 1,800,929 | -10.37 | -37.79% |
| 6 Months | 23.35 | 32.59 | 16.765 | 24.11 | 1,770,338 | -6.28 | -26.90% |
| 1 Year | 19.49 | 33.99 | 16.765 | 24.75 | 1,690,517 | -2.42 | -12.42% |
| 3 Years | 21.0445 | 33.99 | 12.24 | 21.20 | 1,670,258 | -3.97 | -18.89% |
| 5 Years | 23.27 | 58.72 | 12.24 | 27.99 | 1,610,625 | -6.20 | -26.64% |
Acadia Pharmaceuticals Description
| Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology. |
